T 0760/12 (HGF/Met modulation/GENENTECH) of 27.11.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T076012.20171127
- Date of decision
- 27 November 2017
- Case number
- T 0760/12
- Petition for review of
- -
- Application number
- 04754499.4
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- MODULATING THE INTERACTION BETWEEN HGF BETA CHAIN AND C-MET
- Applicant name
- Genentech, Inc.
- Opponent name
- GLAXO GROUP LIMITED
Millennium Pharmaceuticals, Inc.
Galaxy Biotech, LLC - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 15(3)
- Keywords
- Oral proceedings - held in absence of appellant
Sufficiency of disclosure - (no) - Catchword
- -
- Citing cases
- G 0002/21
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.